Using Neuroscience to Advance Therapeutics of Pediatric Anxiety

Dr. Daniel Pine is chief of the Section on Development and Affective Neuroscience in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 500 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and president of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.

CME Accreditation:

Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits ™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy:

Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.

Planner and Speaker’s Disclosures: 

Harold Koplewicz, MD, Ron Steingard, MD, and John Q. Young, MD, have nothing to disclose. Daniel Pine, MD, has nothing to disclose.

Recognition of Program Support:

An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.